Stock Earnings

Question 1

Prime Medicine Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Prime Medicine Inc'in toplam varlıkları $297 olup, net loss $-195'dir.

Question 2

PRME'ün temel finansal oranları nelerdir?

Accepted Answer

Prime Medicine Inc'in cari oranı 2.06, net kâr marjı -9,750, hisse başına satış $0.01'dir.

Question 3

Prime Medicine Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Prime Medicine Inc largest revenue segment is Genetic Therapies, at a revenue of 2,983,000 in the most earnings release.For geography, United States is the primary market for Prime Medicine Inc, at a revenue of 2,983,000.

Question 4

Prime Medicine Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Prime Medicine Inc'in net loss $-195'dir.

Question 5

Prime Medicine Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Prime Medicine Inc'in yükümlülüğü 144'dir.

Question 6

Prime Medicine Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Prime Medicine Inc'in toplam tedavüldeki hisse sayısı 131.16'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	4	2	0	0	0	5
Revenue Growth (YoY)	--	--	--	--	-100%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	52	50	43	29	13	3
Research & Development	156	155	147	86	70	2
Operating Expenses	209	205	204	116	84	6
Other Non Operating Income (Expenses)	0	0	8	1	-80	-11
Pretax Income	-199	-195	-198	-122	-165	-1
Income Tax Expense	0	0	0	0	0	1
Net Income	-199	-195	-198	-142	-184	-5
Net Income Growth	-8%	-2%	39%	-23%	3,579.99%	150%
Shares Outstanding (Diluted)	129.18	118.6	90.96	97.21	94.34	94.34
Shares Change (YoY)	8%	30%	-6%	3%	0%	0%
EPS (Diluted)	-1.54	-1.65	-2.17	-1.46	-1.95	-0.05
EPS Growth	-15%	-24%	49%	-25%	3,800%	67%
Free Cash Flow	-106	-130	-174	-147	-38	-6
Free Cash Flow Per Share	-0.82	-1.09	-1.91	-1.51	-0.4	-0.06
Gross Margin	--	--	--	--	--	--
Operating Margin	-5,100%	-10,100%	0%	0%	0%	0%
Profit Margin	-4,975%	-9,750%	0%	0%	0%	-100%
Free Cash Flow Margin	-2,650%	-6,500%	0%	0%	0%	-120%
EBITDA	-198	-196	-200	-114	-84	0
EBITDA Margin	-4,950%	-9,800%	0%	0%	0%	0%
D&A For EBITDA	6	6	4	2	0	0
EBIT	-204	-202	-204	-116	-84	0
EBIT Margin	-5,100%	-10,100%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	-100%

Prime Medicine Inc (PRME) Price

PRME Stock Price Chart

PRME Income

Follow-Up Questions